Enhanced expression of N-myc messenger RNA in neuroblastomas found by mass screening

Clinical Cancer Research

Volumn 6, Issue 8, 2000, Pages 3199-3204

  Matsunaga, Tadashi ^a   Shirasawa, Hiroshi ^a   Hishiki, Tomoro ^a   Yoshida, Hideo ^a   Kouchi, Katsunori ^b   Ohtsuka, Yasuhiro ^a   Kawamura, Kenji ^a   Etoh, Takao ^c   Ohnuma, Naomi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Matsudo Municipal Hospital   (Japan)

^c CHIBA CHILDREN'S HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; CANCER SCREENING; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MASS SCREENING; NEUROBLASTOMA; ONCOGENE C MYB; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE; QUANTITATIVE ASSAY;

DISEASE-FREE SURVIVAL; GENE EXPRESSION; GENES, MYC; GENES, SRC; HUMANS; INFANT; MASS SCREENING; MULTIVARIATE ANALYSIS; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-MYC; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RECEPTOR, TRKA; RNA, MESSENGER;

EID: 0033897692     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H., and Bishop, J. M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (Washington DC), 224: 1121-1124, 1984.
2. Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Stege, S. E., Wong, K. Y., and Hammond, D. Association of multiple copies of N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 313: 1111-1116, 1985.
3. Nakagawara, A., Arima, M., Azar, C. G., Scavarda, N. J., and Brodeur, G. M. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res., 52: 1364-1368, 1992.
4. Nakagawara, A., Arima-Nakagawara, M., Scavarda, N. J., Azar, C. G., Cantor, A. B., and Brodeur, G. M. Association between high levels of expression of the trk gene and favorable outcome in human neuroblastoma. N. Engl. J. Med., 328: 847-854, 1993.
5. Tanaka, T., Slamon, D. J., Shimada, H., Waki, C., Kawaguchi, Y., Tanaka, Y., and Ida, N. Expression of Ha-ras oncogene products in human neuroblastomas and the significant correlation with a patient's prognosis. Cancer Res., 48: 1030-1034, 1988.
6. Tanaka, T., Slamon, D. J., Shimada, H., Shimoda, H., Fujisawa, T., Ida, N., and Seeger, R. C. A significant association of Ha-ras p21 in neuroblastoma cells with patient prognosis. Cancer (Phila.), 68: 1296-1302, 1991.
7. Matsunaga, T., Shirasawa, H., Tanabe, M., Ohnuma, N., Kawamura, K., Etoh, T., Takahashi, H., and Simizu, B. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas. Int. J. Cancer, 58: 793-798, 1994.
8. Matsunaga, T., Shirasawa, H., Enomoto, H., Yoshida, H., Iwai, I., Tanabe, M., Kawamura, K., Etoh, T., and Ohnuma, N. Neuronal src and trk A protooncogene expression in neuroblastomas and patient prognosis. Int. J. Cancer, 79: 226-231, 1998.
9. Sawada, T., Nishi, M., Takeda, T., and Iehara, T. Mass screening for neuroblastoma in Japan. Med. Pediatr. Oncol., 31: 421-425, 1998.
10. Woods, W. G., Tuchman, M., Robison, L. L., Bernstein, M., Leclerc, J. M., Brisson, L. C., Brossard, J., Hill, G., Shuster, J., Luepker, R., Byrne, T., Weitzman, S., Bunin, G., and Lemieux, B. A population-based study of the usefulness of screening for neuroblastoma. Lancet, 348: 1682-1687, 1996.
11. Kaneko, Y., Kanda, N., Maseki, N., Nakachi, K., Takeda, T., Okabe, I., and Sakurai, I. Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study. J. Clin. Oncol., 8: 2005-2013, 1990.
12. Jakobovits, A., Schwab, M., Bishop, J. M., and Martin, G. R. Expression of N-myc in teratocarcinoma stem cells and mouse embryos. Nature (Lond.), 318: 188-191, 1985.
13. Zimmerman, K. A., Yancopoulos, G. D., Collum, R. G., Smith, R. K., Kohl, N. E., Denis, K. A., Nau, M. M., Witte, W. N., Toran-Allerand, D., Gee, C. E., Minna, J. D., and Alt, F. W. Differential expression of myc family genes during murine development. Nature (Lond.), 319: 780-783, 1986.
14. Thiele, C. J., Reynolds, C. P., and Israel, M. A. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature (Lond.), 313: 404-406, 1985.
15. Matsunaga, T., Takahashi, H., Ohnuma, N., Tanabe, M., Yoshida, H., Iwai, J., Shirasawa, H., and Simizu, B. Expression of N-myc and c-src protooncogenes correlating to the undifferentiated phenotype and prognosis of primary neuroblastomas. Cancer Res., 51: 3148-3152, 1991.
16. Schwab, M., Ellison, J., Busch, M., Rosenau, W., Varmus, H. E., and Bishop, J. M. Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc. Natl. Acad. Sci. USA, 81: 4940-4944, 1984.
17. Kohl, N. E., Gee, C. E., and Alt, F. W. Activated expression of the N-myc gene in human neuroblastomas and related tumors. Science (Washington DC), 226; 1335-1336, 1984.
18. Nakagawara, A., Sasazuki, T., Akiyama, H., Kawakami, K., Kuwano, A., Yokoyama, T., and Kume, K. N-myc oncogene and stage IV-S neuroblastoma. Cancer (Phila.), 65: 1960-1967, 1990.
19. Nisen, P. D., Waber, P. G., Rich, M. A., Pierce, S., Garvin, J. R., Jr., Gilbert, F., and Lanzkowsky, P. N-myc oncogene RNA expression in neuroblastoma. J. Natl. Cancer Inst., 80: 1633-1637, 1988.
20. Slave, I., Ellenbogen, R., Jung, W-H., Vawter, G. F., Kretschmar, C., Grier, H., and Korf, B. R. myc gene amplification and expression in primary human neuroblastoma. Cancer Res., 50: 1459-1463, 1990.
21. Bordow, S. B., Norris, M. D., Haber, P. S., Marshall, G. M., and Haber, M. Prognostic significance of MYCN oncogene expression in childhood neuroblastoma. J. Clin. Oncol., 16: 3286-3294, 1998.
22. Noonan, K. E., Beck, C., Holmayer, T. A., Chin, J. E., Wunder, J. S., Andrulis, I. L., Gazdar, A. F., Willman, C. L., Griffith, B., Von Hoff, D. D., and Roninson, I. B. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 87: 7160-7164, 1990.
23. Matsunaga, T., Shirasawa, H., Tanabe, M., Ohnuma, N., Takahashi, H., and Simizu, B. Expression of alternatively spliced src messenger RNAs related to neuronal differentiation in human neuroblastomas. Cancer Res., 53: 3179-3185, 1993.
24. Sugimoto, T., Sawada, T., Matsumura, T., Kemshead, I. T., Ishii, T., Horii, Y., Morioka, H., Morita, M., and Reynolds, C. P. Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient. Cancer Res., 46: 4765-4769, 1986.
25. Evans, A. E., D'Angio, G. J., Propert, K., Anderson J., and Hann, H-W. L. Prognostic factors in neuroblastoma. Cancer (Phila.), 59: 1853-1859, 1987.
26. Brodeur, G. M., Ambros, P. F., and Favrot, M. C. Biological aspects of neuroblastoma screening. Med. Pediatr. Oncol., 31: 394-400, 1998.
27. Yamamoto, K., Hanada, R., Kikuchi, A., Ichikawa, M., Aihara, T., Oguma, E., Moritani, T., Shimanuki, Y., Tanimura, M., and Hayashi, Y. Spontaneous regression of localized neuroblastoma detected by mass screening. J. Clin. Oncol., 16: 1265-1269, 1998.
28. Kaplan, D. R., Hempstead, B. L., Martin-Zanca, D., Chao, M. V., and Parada, L. F. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science (Washington DC), 252: 554-558, 1991.
29. Klein, R., Jing, S., Nanduri, V., O'Rouke, E., and Barbacid, M. The trk proto-oncogene encodes a receptor for nerve growth factor. Cell, 65: 189-197, 1991.
30. Loeb, D. M., Maragos, J., Martin-Zanca, D., Chao, M. V., Parada, L. F., and Greene, L. A. The trk proto-oncogene rescues NGF responsiveness in mutant NGF-nonresponsive PC12 cell lines. Cell, 66: 961-966, 1991.
31. Smeyne, R. J., Klein, R., Schnapp, A., Long, L. K., Bryant, S., Lwein, A., Lira, S. A., and Barbacid, M. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature (Lond.), 368: 246-249, 1994.
32. D'Arcangelo, G., and Halegoua, S. A branched signaling pathway for nerve growth factor is revealed by src-, ras-, and raf-mediated gene inductions. Mol. Cell. Biol., 13: 3146-3155, 1993.
33. Rusanescu, G., Qi, H., Thomas, S. M., Brugge, J. S., and Halegoua, S. Calcium infulux induces neurite growth through a src-ras signaling cassette. Neuron, 15: 1415-1425, 1995.
34. Kuo, W-L., Chung, K-C., and Rosner, M. R. Differentiation of central nervous system neuronal cells by fibroblast-derived growth factor requires at least two signaling pathway: roles for ras and. src. Mol. Cell. Biol., 17: 4633-4643, 1997.
35. src kinase activity during neuronal differentiation of cultured human neuroblastoma cells. Mol. Cell. Biol., 10: 361-370, 1990.
36. Pyper, J. M., and Bolen, J. B. Identification of a novel neuronal c-src exon expressed in human brain. Mol. Cell. Biol., 10: 2035-2040, 1990.
37. Hishiki, T., Nimura, Y., Isogai, E., Kondo, K., Ichimiya, S., Nakamura, Y., Ozaki, T., Sakiyama, S., Hirose, M., Seki, N., Takahashi, H., Ohnuma, N., Tanabe, M., and Nakagawara, A. Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing c-ret, GFRα-1, and GFRα-2. Cancer Res., 58: 2158-2165, 1998.
38. Melillo, R. M., Barone, M. V., Lupoli, G., Cirafici, A. M., Carlomagno, F., Visconti, R., Matoskova, B., Di Fiore, P. P., Vecchio, G., Fusco, A., and Santoro, M. Ret-mediated mitogenesis requires Src kinase activity. Cancer Res., 59: 1120-1126, 1999.
39. Rosen, N., Reynolds, C. P., Thiele, C. J., Biedler, J. L., and Israel, M. A. Increased N-myc expression following progressive growth of human neuroblastoma. Cancer Res., 46: 4139-4142, 1986.
40. Weiss, W. A., Aldape, K., Mohapatra, G., Feuerstein, B. G., and Bishop, J. M. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J., 16: 2985-2995, 1997.
41. Sakamuro, D., Elliott, K. J., Wechsler-Reya, R., and Prendergast, G. C. BIN1 is a novel MYC-interacting protein with features of a tumor suppressor. Nat. Genet., 14: 69-77, 1996.
42. Galderisi, U., Di Bernardo, G., Cipollaro, M., Jori, F. P., Piegari, E., Cascino, A., Peluso, G., and Melone, M. A. B. Induction of apoptosis and differentiation in neuroblastoma and astrocytoma cells by the overexpression of Bin1, a novel myc interacting protein. J. Cell. Biochem., 74: 313-322, 1999.
43. Lutz, W., Fulda, S., Jeremias, I., Debatin, K-M., and Schwab, M. MycN, and INFγ cooperate in apoptosis of human neuroblastoma cells. Oncogene, 17: 339-346, 1998.
44. Fulda, S., Lutz, W., Jeremias, I., Schwab, M., and Debatin, K-M. MycN sensitizes neuroblastoma cells for drug-induced apoptosis. Oncogene, 18: 1479-1486, 1999.